Literature DB >> 19006613

Recent advances in IBD pathogenesis: genetics and immunobiology.

David Q Shih1, Stephan R Targan, Dermot McGovern.   

Abstract

The inflammatory bowel diseases (IBDs), Crohn's disease and ulcerative colitis, are chronic inflammatory disorders caused by dysregulated immune responses in genetically predisposed individuals. Although the precise etiology of IBD remains unclear, accumulating data, including genome-wide association studies, have advanced our understanding of its immunopathogenesis. This review highlights the role in gut homeostasis and IBD pathogenesis of autophagy, the interleukin (IL)-23/IL-17 axis, and a novel member of the tumor necrosis factor family, TL1A. It focuses on advances in our understanding of IBD from the past year, including advances in genetics and immunobiology.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19006613      PMCID: PMC2734390          DOI: 10.1007/s11894-008-0104-x

Source DB:  PubMed          Journal:  Curr Gastroenterol Rep        ISSN: 1522-8037


  47 in total

Review 1.  Autophagy as an important process in gut homeostasis and Crohn's disease pathogenesis.

Authors:  Ramnik J Xavier; Alan Huett; John D Rioux
Journal:  Gut       Date:  2008-02-13       Impact factor: 23.059

Review 2.  Induction and effector functions of T(H)17 cells.

Authors:  Estelle Bettelli; Thomas Korn; Mohamed Oukka; Vijay K Kuchroo
Journal:  Nature       Date:  2008-06-19       Impact factor: 49.962

3.  Replication of signals from recent studies of Crohn's disease identifies previously unknown disease loci for ulcerative colitis.

Authors:  Andre Franke; Tobias Balschun; Tom H Karlsen; Jürgen Hedderich; Sandra May; Tim Lu; Dörthe Schuldt; Susanna Nikolaus; Philip Rosenstiel; Michael Krawczak; Stefan Schreiber
Journal:  Nat Genet       Date:  2008-04-27       Impact factor: 38.330

4.  Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease.

Authors:  Jeffrey C Barrett; Sarah Hansoul; Dan L Nicolae; Judy H Cho; Richard H Duerr; John D Rioux; Steven R Brant; Mark S Silverberg; Kent D Taylor; M Michael Barmada; Alain Bitton; Themistocles Dassopoulos; Lisa Wu Datta; Todd Green; Anne M Griffiths; Emily O Kistner; Michael T Murtha; Miguel D Regueiro; Jerome I Rotter; L Philip Schumm; A Hillary Steinhart; Stephan R Targan; Ramnik J Xavier; Cécile Libioulle; Cynthia Sandor; Mark Lathrop; Jacques Belaiche; Olivier Dewit; Ivo Gut; Simon Heath; Debby Laukens; Myriam Mni; Paul Rutgeerts; André Van Gossum; Diana Zelenika; Denis Franchimont; Jean-Pierre Hugot; Martine de Vos; Severine Vermeire; Edouard Louis; Lon R Cardon; Carl A Anderson; Hazel Drummond; Elaine Nimmo; Tariq Ahmad; Natalie J Prescott; Clive M Onnie; Sheila A Fisher; Jonathan Marchini; Jilur Ghori; Suzannah Bumpstead; Rhian Gwilliam; Mark Tremelling; Panos Deloukas; John Mansfield; Derek Jewell; Jack Satsangi; Christopher G Mathew; Miles Parkes; Michel Georges; Mark J Daly
Journal:  Nat Genet       Date:  2008-06-29       Impact factor: 38.330

5.  Regulation of gut inflammation and th17 cell response by interleukin-21.

Authors:  Daniele Fina; Massimiliano Sarra; Massimo C Fantini; Angelamaria Rizzo; Roberta Caruso; Flavio Caprioli; Carmine Stolfi; Iris Cardolini; Marta Dottori; Monica Boirivant; Francesco Pallone; Thomas T Macdonald; Giovanni Monteleone
Journal:  Gastroenterology       Date:  2008-01-17       Impact factor: 22.682

6.  Interleukin-23 restrains regulatory T cell activity to drive T cell-dependent colitis.

Authors:  Ana Izcue; Sophie Hue; Sofia Buonocore; Carolina V Arancibia-Cárcamo; Philip P Ahern; Yoichiro Iwakura; Kevin J Maloy; Fiona Powrie
Journal:  Immunity       Date:  2008-04       Impact factor: 31.745

7.  Genetic determinants of ulcerative colitis include the ECM1 locus and five loci implicated in Crohn's disease.

Authors:  Sheila A Fisher; Mark Tremelling; Carl A Anderson; Rhian Gwilliam; Suzannah Bumpstead; Natalie J Prescott; Elaine R Nimmo; Dunecan Massey; Carlo Berzuini; Christopher Johnson; Jeffrey C Barrett; Fraser R Cummings; Hazel Drummond; Charlie W Lees; Clive M Onnie; Catherine E Hanson; Katarzyna Blaszczyk; Mike Inouye; Philip Ewels; Radhi Ravindrarajah; Andrew Keniry; Sarah Hunt; Martyn Carter; Nick Watkins; Willem Ouwehand; Cathryn M Lewis; Lon Cardon; Alan Lobo; Alastair Forbes; Jeremy Sanderson; Derek P Jewell; John C Mansfield; Panos Deloukas; Christopher G Mathew; Miles Parkes; Jack Satsangi
Journal:  Nat Genet       Date:  2008-04-27       Impact factor: 38.330

8.  The TNF-family receptor DR3 is essential for diverse T cell-mediated inflammatory diseases.

Authors:  Françoise Meylan; Todd S Davidson; Erin Kahle; Michelle Kinder; Krishika Acharya; Dragana Jankovic; Virgilio Bundoc; Marcus Hodges; Ethan M Shevach; Andrea Keane-Myers; Eddie C Y Wang; Richard M Siegel
Journal:  Immunity       Date:  2008-06-19       Impact factor: 31.745

9.  TL1A-DR3 interaction regulates Th17 cell function and Th17-mediated autoimmune disease.

Authors:  Bhanu P Pappu; Anna Borodovsky; Timothy S Zheng; Xuexian Yang; Ping Wu; Xingwen Dong; Shawn Weng; Beth Browning; Martin L Scott; Li Ma; Lihe Su; Qiang Tian; Pascal Schneider; Richard A Flavell; Chen Dong; Linda C Burkly
Journal:  J Exp Med       Date:  2008-04-14       Impact factor: 14.307

10.  Essential role of TNF receptor superfamily 25 (TNFRSF25) in the development of allergic lung inflammation.

Authors:  Lei Fang; Becky Adkins; Vadim Deyev; Eckhard R Podack
Journal:  J Exp Med       Date:  2008-04-14       Impact factor: 14.307

View more
  47 in total

1.  Epstein-Barr virus replication linked to B cell proliferation in inflamed areas of colonic mucosa of patients with inflammatory bowel disease.

Authors:  Sumathi Sankaran-Walters; Kanat Ransibrahmanakul; Irina Grishina; Jason Hung; Enrique Martinez; Thomas Prindiville; Satya Dandekar
Journal:  J Clin Virol       Date:  2010-10-28       Impact factor: 3.168

Review 2.  Future biologic targets for IBD: potentials and pitfalls.

Authors:  Gil Y Melmed; Stephan R Targan
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2010-02       Impact factor: 46.802

Review 3.  New insights into the role of fatty acids in the pathogenesis and resolution of inflammatory bowel disease.

Authors:  Darla R Shores; David G Binion; Bruce A Freeman; Paul R S Baker
Journal:  Inflamm Bowel Dis       Date:  2010-12-03       Impact factor: 5.325

4.  Anti-inflammatory Effects of Ganoderma lucidum Triterpenoid in Human Crohn's Disease Associated with Downregulation of NF-κB Signaling.

Authors:  Changda Liu; David Dunkin; Joanne Lai; Ying Song; Clare Ceballos; Keith Benkov; Xiu-Min Li
Journal:  Inflamm Bowel Dis       Date:  2015-08       Impact factor: 5.325

5.  Impact of resolvin E1 on murine neutrophil phagocytosis in type 2 diabetes.

Authors:  Bruno S Herrera; Hatice Hasturk; Alpdogan Kantarci; Marcelo O Freire; Olivia Nguyen; Shevali Kansal; Thomas E Van Dyke
Journal:  Infect Immun       Date:  2014-12-08       Impact factor: 3.441

Review 6.  Insights into IBD Pathogenesis.

Authors:  David Q Shih; Stephan R Targan
Journal:  Curr Gastroenterol Rep       Date:  2009-12

Review 7.  Interleukin-17 and systemic lupus erythematosus: current concepts.

Authors:  A Nalbandian; J C Crispín; G C Tsokos
Journal:  Clin Exp Immunol       Date:  2009-08       Impact factor: 4.330

Review 8.  IL-17 in systemic lupus erythematosus.

Authors:  José C Crispín; George C Tsokos
Journal:  J Biomed Biotechnol       Date:  2010-04-06

9.  Assessment of Growth Disturbance in Japanese Children with IBD.

Authors:  Tetsuo Shono; Mayuko Kato; Yo Aoyagi; Hidenori Haruna; Tohru Fujii; Takahiro Kudo; Yoshikazu Ohtsuka; Toshiaki Shimizu
Journal:  Int J Pediatr       Date:  2010-05-05

10.  Serological markers for inflammatory bowel disease in AIDS patients with evidence of microbial translocation.

Authors:  Anupa Kamat; Petronela Ancuta; Richard S Blumberg; Dana Gabuzda
Journal:  PLoS One       Date:  2010-11-15       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.